Alaunos Therapeutics | ZIOP - Des Atouts





Des Atouts Changement Date
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 115.83B 1.82B 2026-06
Baxter International USD 19.79B 55M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Bioline Rx USD 38.8M 2.11M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Celltrion KRW 768.81B 9.37B 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Curis USD 19.97M 9.27M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Incyte USD 7.87B 533.53M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 201.06B 167M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Merck USD 128.68B 8.18B 2026-03
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Novartis USD 122.03B 3.5B 2026-06
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pfizer USD 207.62B 542M 2026-03
Pharma Mar EUR 385.26M 9.82M 2026-03
PTC Therapeutics USD 3.25B 381.37M 2026-06
Qiagen NV USD 5.78B 513.9M 2026-03
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
TG Therapeutics USD 1.53B 465.58M 2026-03
Tilray USD 2.1B 15.95M 2025-09
Verastem USD 246.44M 69.59M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03